author-photo

Alberto Bosi

University of Florence

598

Papers

16673

Citations

Citation Trend

Filter By

Papers (434) Sort By

Journal Conference Others

Serum TARC Concentration Kinetic in Classical Hodgkin Lymphoma during First-Line Treatment

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Non scarring patchy alopecia: What else, apart from alopecia areata?

2021 Journal of Cutaneous Pathology
Show All
- Source
- Cite
- Save
Citations (0)
Multilineage Dysplasia as Assessed by Immunophenotype in Acute Myeloid Leukemia: A Prognostic Tool in a Genetically Undefined Category.

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
Minimal Residual Disease (MRD) at 10-6 Measured By Next Generation Flow (NGF) during Daratumumab Consolidation Therapy: Analysis at 18 Months Follow up of DART4MM Study (Daratumumab Treatment For Multiple Myeloma Eradication)

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Phenotypic Correlates and Prognostic Outcomes of TET2 Mutations in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes: A Comprehensive Study of 504 Adult Patients

2020 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (1)
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk.

2020 Journal of Hematology & Oncology
Show All
- Source
- Cite
- Save
Citations (15)
One-Year Outcomes From a Phase 3 Randomized Trial of Ravulizumab in Adults With Paroxysmal Nocturnal Hemoglobinuria Who Received Prior Eculizumab.

2020 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (1)
Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm

2020 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (6)
Treatment and prognosis of primary pulmonary lymphoma: a long-term follow-up study

2020 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of daratumumab, bortezomib, and dexamethasone (D-Vd) in relapsed or refractory multiple myeloma (RRMM) based on cytogenetic risk: Updated subgroup analysis of CASTOR.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)